4971 - 4980 of 8587 Results
Title
Year
- Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian Ancestry2024OPENTitle: Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian AncestryJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 8Start Page: 1424End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29821Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29821Citation Count: 0
-
OPENTitle: Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100113End Page: 100113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100113Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100113Citation Count: 12
-
RESTRICTEDTitle: Repeated Spiral Drawings in Essential Tremor: a Possible Limb-Based Measure of Motor LearningJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-018-0974-xCitation Count: 5
- Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease2018RESTRICTEDTitle: Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 621End Page: 639Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1892-1Citation Count: 58
- Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting2022OPENTitle: Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative LightingJournal Name: LEUKOSPublisher: Informa UK LimitedVol: 19Issue #: 3Start Page: 294End Page: 307Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15502724.2022.2123816Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15502724.2022.2123816Citation Count: 8
- Evidence for topographic guidance of dopaminergic axons by differential Netrin-1 expression in the striatum2014RESTRICTEDTitle: Evidence for topographic guidance of dopaminergic axons by differential Netrin-1 expression in the striatumJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 61Issue #:Start Page: 85End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2014.05.003Citation Count: 34
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 12
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
- Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration2022OPENTitle: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegenerationJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e1010138End Page: e1010138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1010138Best OA location URL: https://doi.org/10.1371/journal.pgen.1010138Citation Count: 8
- Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy2022OPENTitle: Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 4Start Page: e0266405End Page: e0266405Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0266405Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0266405&type=printableCitation Count: 5